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478a Tuesday, February 18, 2014thermodynamics as well as in the introduction of the small molecule ligands
on fast time scales. An attractive strategy is to ‘cage’ the protein ligand with
a photochemically cleavable protecting grou which, upon photolysis, releases
the ligand on nanosecond timescales allowing for the examination of fast
time dynamics associated with ligand-protein interactions. Here, a new class
of photocage is presented based upon the photophysics of Ru(II)bis
(2,20bipyridine)L2 type complexes. Specifically, we present the thermody-




complexes in aqueous solution using photoacousctic calorimetry (PAC) and
density functional theory. Our results are consistent with N donation
form the ligands to the metal dominating the interaction energies and posi-
tive reaction entahlpies. In addition, the relative small changes in molar vol-
ume change suggest the each complex is highly solvated in aqueous
solutions.
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Biophysical methods are essential tools in current front line drug discovery pro-
cesses. They can be used for optimization of protein constructs and verification
of proper and consistent protein folding, identification of optimal assay buffer,
screening of fragments and the confirmation of binding to the right or allosteric
binding site(s) of the target molecule- each approach providing a wealth of in-
formation. With a growing industry need to reduce project attrition (and there-
fore cost) by providing more physiological mechanistic data to aid in the
identification of compounds that translate in vitro activity into in vivo efficacy.
Application of panels of biophysical techniques allow cross correlation of data
and better control of experimental parameters - increasing reliability and con-
fidence in results whilst eliminating artifacts. In this work we show how SPR,
DSC and ITC can be used in the selection and verification of binders in a Frag-
ment Based Drug Discovery campaign by providing quantitative binding infor-
mation to advance true hits for chemistry and later stage biology in hit to lead
development.
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Propofol, a dialkylphenol intravenous anesthetic, has been widely administered
for over a quarter century in general anesthesia and for rapid sedation. Regard-
less, the drug’s mechanism of action remains elusive with mounting evidence
suggesting contributions from multiple pathways. Most proposed targets, such
as ion channels and ligand gated receptors, are low abundance but functionally
important proteins. To uncover these significant targets, we synthesized a pho-
toactive- and ‘clickable’- propofol analogue with meta-trifluoromethyldiazir-
inyl and ortho-(propynyloxy)methyl substitutions in place of the two
isopropyl groups. This novel o-alkynyl-m-azipropofol maintains the physio-
chemical, biochemical and in vivo properties of propofol. It also photoadducts
to known propofol binding sites in model proteins. Once adducted, the alkyne
click moiety successfully undergoes copper catalyzed 1,3-dipolar cycloaddi-
tion reactions with azide-rodamine and -biotin tags allowing for fluorescent la-
beling and avidin resin enrichment of photolabeled targets within ex vivo
systems. Using fluorescent microscopy or mass spectroscopy, the chemically
‘dual-active’ propofol analogue allows localization and identification of key
targets in the biochemical pathways that underlie alkylphenol induced
anesthesia.
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Thomas Jefferson University, Philadelphia, PA, USA.A multi-dimensional docking analysis was applied to investigate the binding
of general anesthetics against distinct channel isoforms and conformations.
Specifically, MD-generated ensembles of the channel isoforms K-Shaw2,
Kv1.2 and Kv1.2-G329T in the activated-open and resting-closed conforma-
tions were docked against a family of anesthetic chemotypes, composed by
halothane, isoflurane, sevoflurane and propofol. The total 240,000 docking
solutions bind the channel structures at multiple sites split over four major
regions (voltage-sensor, S4-S5 linker, selectivity filter and central cavity)
within a diverse range of binding affinities Kb, ie., 2-50 mM. We followed
a subtraction analysis to resolve channel and conformation dependency of
ligand affinity on each binding site. From the analysis, sites placed at the
S4-S5 linker and at the selectivity filter arise for every ligand as putative re-
gions accounting for differential binding over channel variants and confor-
mations. Although useful to identify sites potentially associated with
differential binding of anesthetics across distinct conformations and isoforms,
the present estimates for binding affinities as provided by Autodock Vina are
largely approximative, thereby limiting concrete connections between the
data and experimental measurements. To circumvent this difficulty, we
have started a long series of FEP calculations to evaluate the binding affinity
of sevoflurane and isoflurane against K-Shaw2 and Kv1.2 in both their
activated-open and resting-closed states. The FEP computations carried so
far have confirmed the differences between conformation affinities on the
S4-S5 linker region for the Kv1.2 isoform. Taken together, our results reveal
binding sites that may underlie channel specific effects of general anesthetics
providing thus new directions for further experimental investigation of this
topic.
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TRPM2 is a Ca2þ-permeable cation channel that belongs to the M subfamily of
Transient Receptor Potential (TRP) channel proteins. TRPM2 is a homote-
tramer, each monomer contains a cytosolic N-terminal TRPM-homology re-
gion, six transmembrane helices with an architecture typical to that of
voltage-gated cation channels, and a cytosolic coiled-coil region followed by
a NUDT9-Homology (NUDT9H) domain at the C-terminus.
TRPM2 activates in the presence of Ca2þ, ADP-Ribose (ADPR), and PIP2
(Toth and Csanady, 2012). ADPR binds to the NUDT9H-domain which dis-
plays ~35% identity with NUDT9, a monomeric mitochondrial ADPR-
pyrophosphatase with available crystal structure (Shen et al., 2003). At pre-
sent, it is unclear whether NUDT9H is an active enzyme itself, or just an
ADPR-binding domain. In contrast to the extremely high solubility of
NUDT9, NUDT9H solubility is very low: when overexpressed in bacterial
systems it forms inclusion bodies, and reprecipitates upon removal of chaot-
ropic agents. This might be a consequence of the tetrameric nature of
TRPM2, in the context of which it is unclear how the four N-terminal domains
and the four NUDT9H domains interact with each other and/or with the trans-
membrane segments. The fact that ADPR binding to NUDT9H is necessary
for channel activation suggests an extended interface between NUDT9H and
some partnering segment within the complex. Surface exposure of this inter-
face region may account for the reduced solubility of NUDT9H when ex-
pressed in isolation.
Here we explore this hypothesis by expressing soluble NUDT9, insoluble
NUDT9H, as well as different NUDT9/NUDT9H chimeras. By monitoring
the solubility of the chimeras, we attempt to narrow down the search for the
functional interface of NUDT9H. In addition, we try to identify the minimal
substitutions required for increasing NUDT9H solubility. Finally, we use solu-
ble NUDT9 to test hydrolysis of various substrates/ligands that activate the
TRPM2 channel.
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Netrin-1 is a bifunctional guidance cue for migrating axons in vertebrates. De-
pending on the target receptor family netrin-1 interacts with, it either causes
attraction or repulsion of axonal growth cones. Chemoattraction is mediated
by adhering to DCC or its homologue neogenin, whereas chemorepulsion
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UNC5D receptors. In addition to the nervous system, netrin-1 and its recep-
tors have been detected in developing heart, lung, mammary gland, intestine
and pancreas and are believed to be expressed ubiquitously. Both families of
receptors have been implicated as dependence receptors, that is receptors that
induce apoptosis if they are not bound to their ligand such as netrin-1. Thus
they play a pivotal role in the development of the organism and in tumour
suppression.
Here, we present the 2.5 A high resolution structure determined by X-ray
crystallography that comprises four domains of netrin-1. We mapped the
netrin-1/neogenin and the netrin-1/UNC5 binding sites by a series of
domain swap experiments where we exchanged individual domains of
netrin-1 with a structurally closely related -but non-functional- domain of
the laminin g1 short arm. We probed the binding behaviour of the chimeras
by surface plasmon resonance and solid phase binding assays. Once the
binding domain had been unambiguously identified, we determined the
binding epitopes on netrin-1 by mutational analysis, using structural infor-
mation and phylogenetic conservation as guides. We found that the DCC
family and the UNC5 family of receptors bind to spatially distinct sites
within the same domain. Reciprocally, we confirmed that the 5th fibronectin
domain of DCC harbours the binding site for netrin-1 and determined the
binding epitopes. Finally, we show the conformation of the netrin-1/
neogenin complex in solution using SAXS data and present a map of the
binding sites.
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PPTI, proposed as a potential dendrotoxin, which isolated from the venom of
Pseudocerastes persicus has 58 amino acid residues and cross-linked by three
disulfide bonds. We explored the interaction between PPTI and ShaKv1.1 po-
tassium channel by successive application of protein-protein docking and
molecular dynamic simulation. The analysis of the complexes revealed that
the Lys5 residue of PPTI plugged its side chain into the channel selectivity
filter. Molecular dynamic simulation in membrane environment of the com-
plex structure resulted in docking stage confirmed the stability of the
complex.
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Protein functions rely on protein motions. Protein structures, obtained with X-
ray diffraction or NMR, reveal mostly static pictures of structure-function rela-
tion. To connect structural changes of proteins with function, we need to look at
events happening in real time, i.e. the dynamics of the processes.
We have chosen mlCNBD as a model protein to study the dynamics of
receptor-ligand complex formation. mlCNBD is a cytosolic cyclic
nucleotide-binding domain of a bacterial potassium channel (MloK1).
mlCNBD binds to cyclic adenosine monophosphate (cAMP) and undergoes
conformational changes as evident from the NMR and X-ray structures of
the apo and holo conformational states of the protein. Recent kinetic and
NMR studies indicate that these structural transitions follow the "induced-fit"
mechanism, i.e. these are a direct consequence of ligand binding. However,
the detailed mechanism of these structural rearrangements leading to receptor
activation remains elusive.
We use transient Electron Paramagnetic Resonance (tr-EPR) spectroscopy in
conjunction with Site- Directed Spin Labelling (SDSL) to resolve the dy-
namics of mlCNBD-cAMP complex formation. We introduce single cysteine
residues at different sites in the protein. The mutants are labelled with
Methane Thio Sulphonate Spin Label (MTSSL). Binding of cAMP to the
mutants is rapidly initiated either via a caged-cAMP approach or through
a micro-mixer. The time-resolved EPR data reveals the progression of struc-
tural changes taking place at a particular site on millisecond time scale.Collating data across the whole protein will enable us to reconstruct the steps
from the apo to the holo state of the protein. It will also provide the answer
to the question whether the "induced-fit" mechanism follows a concerted
(single step) or sequential (multi-step) path from the apo to the holo
conformation.
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GPR119 is a Class A (rhodopsin-like) G-protein coupled receptor that has
insulin-regulating activity. GPR119 agonists stimulate glucose-dependent in-
sulin secretion in vitro and lower elevated blood glucose in vivo. Hence, the
GPR119 receptor has emerged as an important target for the treatment of
type 2 diabetes. An initial GPR119 homology model was constructed
using the adenosine A2A receptor crystal structure bound to an antagonist
at 2.6A˚ resolution (PDB id: 3EML) as the template. The preliminary model
was refined by exploring the flexibility of individual helices using the Monte
Carlo/simulated annealing method, Conformational Memories (CM). CM em-
ploys multiple Monte Carlo/simulated annealing random walks, exploring pep-
tide and protein dihedral conformational space. A pair of previously reported
diastereomers, one of which acts as a GPR119 receptor agonist and the other
as an antagonist, were docked into the active (R*) and inactive (R) receptor
models. The putative binding site of the preliminary R model starts between
the top of transmembrane helices (TMHs) 2 and 7 and spans the bundle in a
shallow diagonal direction, almost perpendicular to the TMH region. The floor
of the binding site is between TMHs 3, 5 and 6 at the level of F234(6.44) (mid-
dle of the TMH bundle). W238(6.48) (c1 = gþ) places its bulk between TMHs
6 and 7. The only charged amino acid that is accessible to the binding site,
R81(3.28), was used as the primary interaction site for both compounds.
The GPR119 R* state binding site is more vertical compared to the R state
and somewhat deeper because of a c1 rotamer change of W238(6.48) to a
trans conformation in the R* state, which places its bulk between TMHs
5 and 6.
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Endothelin receptors (ETRs) are GPCRs whose activation results in the in-
crease of intracellular calcium levels, and are ultimately involved in vasocon-
striction and vasodilation. Because control of ETR activity has important
medical implications, it is beneficial to rapidly discover effective synthetic
ETR ligands by virtual drug screening methods. Despite its biological impor-
tance, little is known about ETR structure, since there are no reported X-ray
structures to date. However, structural information is available for
Endothelin-1, the natural ligand to ETR and the most potent vasoconstrictor
yet identified. Thus, our work takes the ligand-based approach instead of
receptor-based approach to ETR ligand pharmacophore discovery. Two
well-studied ETR ligands, BQ-123 and bosentan, were chosen to be reference
compounds in addition to Endothelin-1, and 30 known synthetic ligands were
defined as the sample active compounds set. Conformers of the sample set
were prepared by genetic algorithm-based approach using OpenBabel, while
conformers of the reference set were prepared by molecular dynamics, using
myPresto/cosgene. For molecular superimpositions, we built and used a pro-
gram called ’BMSIP,’ which is an algorithmic extension of the ROCS pro-
gram. While it performs rigid-body superimpositions using a volume
overlap score function based on spherical Gaussian descriptions of atomic
shape, BMSIP also introduces a scores-weighting matrix to bias atom-
pairings by atom-type correspondence. Superimposition of the sample set
against the reference set was performed to obtain a density map that shows
the frequency of atom overlaps between the superimposed compounds and
reference compounds. This map can indicate the essential chemical features
(the pharmacophore) required for interaction with ETRs. The results suggest
that nonpolar groups alone, in particular aromatic groups, are important for
ETR binding affinity and provide a good initial guess for directed ETR ligand
design.
